Business Context and Reporting Period
Company: Photronics, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: February 1, 2004
Business Overview: Photronics manufactures photomasks, high-precision photographic quartz plates used as masters to transfer circuit patterns onto semiconductor wafers. The company operates nine facilities globally (three in the U.S., three in Europe, and one each in Korea, Singapore, and Taiwan). Demand is driven by integrated circuit design activity rather than semiconductor sales volume.
Key Financial Metrics
| Metric | Three Months Ended Feb 1, 2004 | Three Months Ended Feb 2, 2003 |
|---|---|---|
| Net Sales | $90.5 million | $81.4 million |
| Gross Margin | 31.6% | 21.7% |
| Operating Income | $7.7 million | $(4.4) million (Loss) |
| Net Income | $2.1 million | $(8.5) million (Loss) |
| Earnings Per Share (Diluted) | $0.07 | $(0.26) |
| Cash from Operations | $15.3 million | $(6.8) million |
| Cash & Short-Term Investments | $236.0 million | $131.0 million (approx. based on prior period cash + investments) |
| Total Debt (Current + Long-Term) | $372.8 million | $373.8 million (approx.) |
| Working Capital | $276.1 million | $258.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 11.2% year-over-year, driven by increased new design releases and improved end-user demand. Sales in Asia grew 20.8%, while North America and Europe saw modest growth of 4.8% and 4.0%, respectively.
- Profitability Turnaround: The company returned to profitability, reporting a net income of $2.1 million compared to a net loss of $8.5 million in the prior year. Operating income swung from a $4.4 million loss to a $7.7 million gain.
- Margin Expansion: Gross margin improved significantly to 31.6% from 21.7%, attributed to higher revenues and improved manufacturing utilization following the closure of the Phoenix, Arizona facility in March 2003.
- Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased to $13.5 million (15.0% of sales) from $14.4 million (17.7% of sales) due to reduced salaries and facility costs from consolidation initiatives.
- Cash Flow: Operating cash flow turned positive at $15.3 million, reversing a $6.8 million outflow in the prior year. However, investing activities consumed $101.3 million, primarily due to $91.2 million in short-term investment purchases and $10.7 million in capital expenditures.
Guidance, Outlook, Risks, and Contingencies
- Capital Expenditures: The company expects fiscal 2004 capital expenditures to range between $75.0 million and $85.0 million. Outstanding commitments as of February 1, 2004, were approximately $35.0 million.
- Liquidity: The company maintains a $100 million revolving credit facility with approximately $82 million available as of February 1, 2004. Management believes current resources are sufficient to meet working capital and capital expenditure needs.
- Industry Risks: The semiconductor industry remains volatile. Risks include the migration of manufacturing to Asia, excess capacity, and technological shifts such as direct-write lithography which could reduce the need for photomasks.
- Technology Transition: The company is transitioning to 90-nanometer and 65-nanometer process technologies. While capable of production, competitors may achieve higher yields initially due to more learning cycles.
- Restructuring: Ongoing restructuring charges related to previous facility closures totaled $0.7 million for the quarter. Remaining obligations include $0.9 million for workforce reductions and $5.7 million for non-cancelable leases.
- Market Risk: A 10% adverse movement in foreign exchange rates (Korean won, Singapore dollar, British pound) would result in a pre-tax loss of $3.9 million. Interest rate risk exists on approximately $120 million of variable rate instruments.
Investor Verification Checklist
- Sustainability of Margin Improvement: Verify if the 31.6% gross margin is sustainable or if it is a temporary result of specific holiday period fab closures in 2003 versus 2004.
- Capital Expenditure Execution: Monitor the $75M-$85M CapEx guidance to ensure it aligns with revenue growth and does not strain liquidity.
- Asia vs. North America Mix: Assess the long-term impact of the 20.8% sales growth in Asia versus the 4.8% growth in North America on future cost structures and tax rates.
- Debt Covenants: Review the credit agreement covenants (Debt/EBITDA, Minimum EBITDA/Interest) to ensure continued compliance given the recent profitability turnaround.
- Technology Adoption: Evaluate the company's competitive position in 90nm and 65nm photomask production against competitors with potentially higher yields.